Pancreatic Cancer Research

ResearcherUniversity of North Carolina at CharlotteActive in the last 2 years

Valery Z. Grdzelishvili

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8715-3840; OpenAlex author ID A5085975858; NIH RePORTER profile ID 9035105. Sources: OpenAlex.

Their work

Papers
15 (first author 0, last author 14)
Trials
0
Grants
4
Labs led
1
Collaborators
15
Papers, trials and grants by year

2012: 1 paper, 1 grant · 2013: 4 papers · 2014: none · 2015: 3 papers · 2016: 1 paper, 1 grant · 2017: 1 paper · 2018: none · 2019: 1 grant · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 grant · 2025: 2 papers

Papers 15

  1. Fostamatinib (R788), a spleen tyrosine kinase inhibitor, sensitizes pancreatic cancer cells to oncolytic vesicular stomatitis virus. Last author DOI 10.1016/j.omton.2025.201089↗
  2. METTL3 depletion blocks vesicular stomatitis virus replication in pancreatic cancer cells through the establishment of an intrinsic antiviral state. Last author DOI 10.1128/jvi.02284-24↗
  3. Intertumoral heterogeneity impacts oncolytic vesicular stomatitis virus efficacy in mouse pancreatic cancer cells. Last author DOI 10.1128/jvi.01005-23↗
  4. Acquired chemoresistance can lead to increased resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus. Last author DOI 10.1016/j.omto.2021.11.019↗
  5. Experimental Evolution Generates Novel Oncolytic Vesicular Stomatitis Viruses with Improved Replication in Virus-Resistant Pancreatic Cancer Cells. Last author DOI 10.1128/jvi.01643-19↗
  6. Ruxolitinib and Polycation Combination Treatment Overcomes Multiple Mechanisms of Resistance of Pancreatic Cancer Cells to Oncolytic Vesicular Stomatitis Virus. Last author DOI 10.1128/jvi.00461-17↗
  7. Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus. Last author DOI 10.18632/oncotarget.11202↗
  8. Induction of apoptosis in pancreatic cancer cells by vesicular stomatitis virus. Last author DOI 10.1016/j.virol.2014.10.026↗
  9. An unexpected inhibition of antiviral signaling by virus-encoded tumor suppressor p53 in pancreatic cancer cells. Last author DOI 10.1016/j.virol.2015.04.017↗
  10. Breaking resistance of pancreatic cancer cells to an attenuated vesicular stomatitis virus through a novel activity of IKK inhibitor TPCA-1. Last author DOI 10.1016/j.virol.2015.08.003↗
  11. The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer. Co-author DOI 10.1002/jso.23316↗
  12. Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling. Last author DOI 10.1016/j.virol.2012.11.014↗
  13. Oncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive or MUC1-null pancreatic ductal adenocarcinoma. Last author DOI 10.1128/jvi.01412-13↗
  14. Vesicular Stomatitis Virus as an Oncolytic Agent against Pancreatic Ductal Adenocarcinoma Last author DOI 10.1128/jvi.02979-12↗
  15. Vesicular stomatitis virus as an oncolytic agent against pancreatic ductal adenocarcinoma. Last author DOI 10.1128/jvi.05640-11↗

Grants 4

  1. Understanding and improving novel oncolytic viruses for pancreatic cancer R15CA280729↗
  2. Rational Oncolytic Virotherapy For Pancreatic Cancer Using Vesicular Stomatitis Virus R15CA238864↗
  3. CELLULAR PATHWAYS AFFECTING ONCOLYTIC VIRUS-HOST INTERACTIONS IN CANCER R15CA195463↗
  4. MUC1 AND RESISTANCE OF CANCER CELLS TO ONCOLYTIC VIROTHERAPY R15CA167517↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dakota W. Goad · 3 shared papers, 2022–2025 · strength 0.77
  2. Cassandra Catacalos-Goad · 2 shared papers, 2025 · strength 0.61
  3. Sébastien A. Felt · 4 shared papers, 2015–2017 · strength 0.34
  4. Megan J Moerdyk-Schauwecker · 6 shared papers, 2012–2016 · strength 0.31
  5. Christian Bressy · 1 shared paper, 2022 · strength 0.22
  6. Eric L. Hastie · 4 shared papers, 2013–2016 · strength 0.22
  7. Marcela P. Cataldi · 3 shared papers, 2015–2016 · strength 0.21
  8. Andrea M. Murphy · 5 shared papers, 2012–2013 · strength 0.19
  9. Pinku Mukherjee · 5 shared papers, 2012–2013 · strength 0.19
  10. Sara L. Seegers · 1 shared paper, 2020 · strength 0.15
  11. Dahlia M. Besmer · 4 shared papers, 2012–2013 · strength 0.14
  12. Jennifer M. Curry · 2 shared papers, 2013 · strength 0.07
  13. Lopamudra Das Roy · 1 shared paper, 2013 · strength 0.03
  14. John B. Martinie · 1 shared paper, 2013 · strength 0.03
  15. David A. Iannitti · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.